MQIX

The next-generation rapid diagnosis total platform for infectious diseases

Based on our continuous technological innovation, the platform is complemented to provide a personalized diagnosis.

Accurate and rapid
diagnosis platform

Our continuous technological innovation enables us to create leading world-class products for in vitro diagnostics.

A leader in the global infectious disease rapid diagnosis industry

We lead Korean biotechnology - our state-of-the-art platform quickly and accurately diagnoses infectious diseases.

Realizing corporate values for
human health and happiness for humankind

We realize corporate values for maintaining the balance between human health and happiness for people through rapid and accurate diagnosis.

SCROLL DOWN

We offer many high-quality products

Developing an innovative new drug platform with the technology for selecting and producing high-sensitivity and high-efficiency antibodies and the recombinant fusion protein technology

COVID-19 Ag

Rapid Diagnostic Kit (RDT)
to quickly determine COVID-19 viral infection

It is a rapid diagnostic test (RDT) that can help anyone quickly and accurately detect the SARS-CoV-2 antigen.
It is very useful as a screening test for coronavirus infection (COVID-19)

Core Technologies

15-minute rapid test

Influenza A/B

Rapid Diagnostic Kit (RDT)
to quickly determine Influenza A/B viral infection

It is a rapid diagnostic test (RDT) that can help anyone quickly and accurately
detect the Influenza A/B antigen. It is very useful as a screening test for Influenza A/B infection.

Core Technologies

15-minute rapid test